Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

Completed · Phase 1 · Has a placebo group

Conditions studied: Hypercholesterolemia, LDL Cholesterol

In brief

This study is designed to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of LGT209 in hypercholesterolemic patients taking common statin medications and in healthy volunteers.

Key facts

Study ID
NCT01859455
Run by
Novartis Pharmaceuticals
People needed
25
Starts
2011-07-01
Expected to finish
2012-07-01
Last updated by the study team
2020-12-17

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.